Also of note, per looking up in a Bloomberg terminal right now:
1. The Roth analyst cut his price target to $5 from $6, though no change in projected sales or bottom line is in there. So don’t know if there is a data delay.
2. While I can’t find a report anywhere, it states that the Think Equity analyst reaffirmed an $8 target as of today.